{
    "title": "Future of Biogen's Aduhelm hinges on U.S. Medicare Alzheimer's coverage",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10390353/Future-Biogens-Aduhelm-hinges-U-S-Medicare-Alzheimers-coverage.html",
    "date": "2022-01-11",
    "keywords": [
        "medicare",
        "biogen",
        "coverage",
        "population",
        "health",
        "aduhelm",
        "price",
        "drug",
        "decision",
        "program",
        "approval",
        "brain",
        "access",
        "beasley",
        "administration",
        "disease",
        "government",
        "plan",
        "center",
        "value",
        "agency",
        "fda",
        "evidence",
        "share",
        "jan",
        "future",
        "week",
        "treatment",
        "medicaid",
        "july",
        "policy",
        "food",
        "efficacy",
        "brainwasting",
        "rate",
        "decline",
        "rationale",
        "proof",
        "benefit",
        "healthcare",
        "cleveland",
        "sinai",
        "system",
        "month",
        "list",
        "half",
        "year",
        "toll",
        "age",
        "infusion",
        "antibody",
        "type",
        "plaque",
        "side",
        "class",
        "development",
        "roche",
        "ag",
        "partner",
        "co",
        "evaluation",
        "risk",
        "backlash",
        "community",
        "option",
        "something",
        "middle",
        "use",
        "diverse",
        "impact",
        "registry",
        "capital",
        "june",
        "advocacy",
        "group",
        "monday",
        "earlystage",
        "medication",
        "criticism",
        "target",
        "impairment",
        "chris",
        "leibman",
        "head",
        "amp",
        "monitoring",
        "deena",
        "editing",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}